Results 211 to 220 of about 58,433 (328)

WADD-SEPD Consensus on Psychological Treatment of Dual Disorders II: Neurodevelopmental, Anxiety, Post-Traumatic Stress, Somatic Symptom, Eating, and Personality Disorders and Recommendations for Future Research. [PDF]

J Clin Med
Benito A, Jiménez-Murcia S, Tirado-Muñoz J, Adan A.   +3 more
europepmc   +1 more source

Actigraphy-based sleep outcomes in substance use disorders: A protocol for a systematic review and meta-analysis. [PDF]

PLoS One
Paredes Naveda AM, Oliva HNP, Ghadimi DJ, Angarita GA.   +3 more
europepmc   +1 more source

Characterization of wash-off from urban impervious surfaces and SuDS design criteria for source control under semi-arid conditions.

Science of the Total Environment, 2018
I. Andrés-Doménech, C. Hernández-Crespo, Miguel Martín, V. Andrés-Valeri   +3 more
semanticscholar   +1 more source

Training Addiction Psychiatry Fellows in Insomnia: Survey Results and Recommendations. [PDF]

Acad Psychiatry
Panchal Z, Ritvo A, Mikulich-Gilbertson SK, Camacho J, Sakai JT.   +4 more
europepmc   +1 more source

Suds, Shines and SELLS [PDF]

, 1958

openalex   +1 more source

Evaluating the efficacy of reprocessing contaminated single use devices for re-use in intensive care unit in Ethiopia. [PDF]

Antimicrob Resist Infect Control
Duffa YM, Kasa ZS, Aklilu KK, Senbato FR, Bonger ZT, Seyoum ET, Zeleke ED, Chekol LT, Mekuria Z, Welelaw SM, Balada-Llasat JM, Wang SH, Eguale T.   +12 more
europepmc   +1 more source

Impaired olfactory function in substance use disorder. [PDF]

Psychopharmacology (Berl)
Raithel CU, Sherman GT, Epstein DH, Kahnt T.   +3 more
europepmc   +1 more source

Evaluation of Current Evidence on the Efficacy of Esketamine in Treating Substance-Use Disorders in Patients With Treatment-Resistant Depression (TRD): A Narrative Review. [PDF]

Cureus
Shelke S, Thummalapally RR.
europepmc   +1 more source

Glucagon-like peptide 1 receptor agonists in substance use disorders: A systematic review of ClinicalTrials.Gov. [PDF]

Addict Behav Rep
Patil S, Jha N, Jha MK.
europepmc   +1 more source

Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study.

BMJ
Cai M, Choi T, Xie Y, Al-Aly Z.
europepmc   +1 more source